Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Clearmind Medicine Inc CMND

Healthcare
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CMND)

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

GlobeNewswire October 10, 2024

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy

GlobeNewswire September 16, 2024

Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment

GlobeNewswire September 12, 2024

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

GlobeNewswire September 6, 2024

SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

GlobeNewswire September 6, 2024

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment

GlobeNewswire August 29, 2024

Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment

GlobeNewswire August 21, 2024

Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders

GlobeNewswire August 16, 2024

Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug

GlobeNewswire August 6, 2024
View More News ››

Opinion & Analysis (NDAQ:CMND)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CMND)

BUY BUY BUY BUY BUY

This is gona go up tomorow  
Nibinator - August 21, 2024

Clearmind Medicine Granted U.S. Patent Approval for Binge Be

Breaking News: $CMND Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior TreatmentVancouver, Canada, Aug. 21, 2024 (GLOBE...
whytestocks - August 21, 2024

Clearmind Medicine and Yissum Expand Collaboration with Inte

Just In: $CMND Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic...
whytestocks - August 16, 2024

CMND....Who u trying to kid? Good NR but......

Go ahead.....I dare ya ; ) $50 million shelf offering just filed EFFECTIVE sec.gov/Archives/edgar/data/1892500/000121390023098210...
Iseneschal - June 20, 2024

Clearmind Medicine receives Patent Approval in China for tre

NEWS: $CMND Clearmind Medicine receives Patent Approval in China for treatment of binge behaviours--News Direct-- Clearmind Medicine Inc...
whytestocks - February 26, 2024

CMND....saved all yer a$$es again ; )

Financing announced this a.m Somethings never change
Iseneschal - January 11, 2024
View more Bullboard ››

AJA Health and Wellness Inc.

AJA Health and Wellness Inc.

AJA Health and Wellness Inc. is focused on health and wellness solutions. The Company is engaged in operating a telemedicine ...
View More »